-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Initiates Coverage On Neuronetics with Buy Rating, Announces Price Target of $5

Benzinga·07/20/2026 10:10:02
Listen to the news
BTIG analyst Sam Eiber initiates coverage on Neuronetics (NASDAQ:STIM) with a Buy rating and announces Price Target of $5.